We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

Share Price Information for ADVFN (AFN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 1.00 (10.00%)
Open: 10.50
High: 10.50
Low: 10.50
Prev. Close: 10.50
AFN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results of Open Offer

6 Jan 2023 14:04

RNS Number : 9827L
ADVFN PLC
06 January 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER ARTICLE 7 OF THE EU REGULATION 596/2014 AS IT FORMS PART OF THE UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 6 January 2023

ADVFN plc

("ADVFN" or the ''Company'')

Final Results of Open Offer

The Board of ADVFN is pleased to announce that further to the announcement published earlier today, after scaling back, the Company has conditionally raised gross proceeds of approximately £4.52 million through the issue of 13,708,380 new Open Offer Shares and 4,569,437 Open Offer Warrants at an Issue Price of 33 pence per Open Offer Share in connection with the Open Offer.

Background

On 6 December 2022, ADVFN announced a proposed equity fundraise of up to approximately £6.82 million, before expenses, through an Open Offer pursuant to which Qualifying Shareholders were able to subscribe at an Issue Price of 33 pence per Open Offer Share on the basis of 11 Open Offer Shares for every 14 Existing Ordinary Shares for an aggregate of up to 20,676,322 Open Offer Shares. Qualifying Shareholders were also able to apply for Excess Shares through an Excess Application Facility. On 20 December 2022, the Company announced that the Board had decided to extend the closing date of the Open Offer (as permitted by the terms of the Open Offer) to 11.00am on Thursday, 5 January 2023.

Result of Open Offer

As set out in the Open Offer circular, no allocations of Open Offer Shares will be made to Qualifying Shareholders where such Open Offer Shares would result in any person or persons acquiring or increasing control of the Company within the meaning given in sections 181 and 182 of FSMA, without the relevant regulatory approval of such acquisition or increase of control having first been obtained and not having expired prior to such allocation. Unless the Company is satisfied that such valid approval has been obtained, the Company will reduce the allocations for Open Offer Shares to relevant Qualifying Shareholders such that there is no such acquisition or increase in control of the Company within the meaning given in sections 181 and 182 of FSMA.

Amit Tauman, a director of the Company, applied for his Basic Entitlement in full and applied for Excess Shares under the Excess Application Facility for in aggregate 3,257,151 Offer Shares, amounting to £1,074,860 in aggregate. In addition, his father Yair Tauman applied for his Basic Entitlement in full and for Excess Shares for in aggregate 1,800,000 Offer Shares. As described in the announcement of 6 December 2022, Amit Tauman, together with his father Yair Tauman, has applied to the FCA for further approval to hold up to 29.9 per cent. of the Company's issued share capital (the "FCA Approval") and pending such approval, 2,199,575 Open Offer Shares have been issued to Amit Tauman and 742,424 Open Offer Shares have been issued to Yair Tauman. The balance of 1,057,576 Open Offer Shares subscribed by Amit Tauman and 1,057,576 Open Offer Shares subscribed by Yair Tauman will be subsequently issued upon the receipt of the FCA Approval. On completion of the Open Offer, Amit Tauman will be interested in aggregate 4,380,395 Ordinary Shares representing 10.95 per cent. of the Enlarged Issued Share Capital and his father Yair Tauman will be interested in aggregate 3,619,104 Ordinary Shares representing 9.04 per cent. of the Enlarged Issued Share Capital.

In addition, the Company received an application from a registered nominee under the Open Offer for 3,194,725 Offer Shares which, if issued in full, would result in an underlying shareholder holding in excess of 9.9 per cent. of the Company's Enlarged Issued Share Capital without approval within the meaning given in sections 181 and 182 of FSMA. Accordingly, the Company has reduced the allocation for Open Offer Shares to the registered nominee to 1,685,634 Open Offer Shares.

Accordingly, following the scaling back of applications to comply with the provisions of FSMA as described above, a total of 13,708,380 new Ordinary Shares and 4,569,437 Open Offer Warrants have been issued in connection with the Open Offer, raising a total of £4.52 million. Save as explained above, all Qualifying Shareholders who have validly applied for Open Offer Shares will receive their Basic Entitlement and any application made under Excess Application Facility in full. In addition, as previously announced, one (1) Open Offer Warrant will be issued for every three (3) Open Offer Shares successfully subscribed for.

The Open Offer is conditional upon Admission occurring. Application has been made to the London Stock Exchange for 13,708,380 new Ordinary Shares to be admitted to trading on AIM and it is expected that Admission will become effective and dealings will commence in the New Ordinary Shares at 8.00 a.m. on 9 January 2023. The Open Offer Shares shall rank pari passu in all respects with all other Ordinary Shares then in issue.

Following Admission, the Company will have 40,023,699 Ordinary Shares in issue and admitted to trading on AIM

This announcement should be read in conjunction with the full text of the circular issued on 6 December 2022 ("Circular"). All capitalised/defined terms used in this announcement and not otherwise defined shall have the meanings given to them in the Circular.

A copy of this announcement is available on the Company's website, www.advfnplc.com.

For further information please contact:

ADVFN plc

Amit Tauman (CEO)

+44 (0) 203 8794 460

Beaumont Cornish Limited (Nominated Adviser)

Michael Cornish

Roland Cornish

+44 (0) 207 628 3396

Peterhouse Capital Limited (Broker)

Eran Zucker

+44 (0) 207 469 0930

IMPORTANT NOTICES

Beaumont Cornish Limited ("Beaumont Cornish"), which is authorised and regulated in the United Kingdom by the FCA and is a member of the London Stock Exchange, is the Company's nominated adviser for the purposes of the AIM Rules. Beaumont Cornish is acting exclusively for the Company and will not regard any other person (whether or not a recipient of this announcement) as a client and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice in relation to the contents of this document or any other matter referred to herein. Beaumont Cornish's responsibilities as the Company's nominated adviser under the AIM Rules for Nominated Advisers are owed to the London Stock Exchange and not to any other person and in particular, but without limitation, in respect of their decision to acquire Open Offer Shares or Open Offer Warrants in reliance on any part of this announcement. Beaumont Cornish has not authorised the contents of this announcement for any purpose and no liability whatsoever is accepted by Beaumont Cornish nor does it make any representation or warranty, express or implied, as to the accuracy of any information or opinion contained in this announcement or for the omission of any information. Beaumont Cornish expressly disclaims all and any responsibility or liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement.

Peterhouse House Capital Limited ("Peterhouse"), which is authorised and regulated in the United Kingdom by the FCA and is a member of the London Stock Exchange, is the Company's broker for the purposes of the AIM Rules. Peterhouse is acting exclusively for the Company and will not regard any other person (whether or not a recipient of this announcement) as a client and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice in relation to the contents of this announcement or any other matter referred to herein. Peterhouse has not authorised the contents of this announcement for any purpose and no liability whatsoever is accepted by Peterhouse nor does it make any representation or warranty, express or implied, as to the accuracy of any information or opinion contained in this announcement or for the omission of any information. Peterhouse expressly disclaims all and any responsibility or liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement.

No representation, responsibility or warranty, expressed or implied, is made by ADVFN plc, Beaumont Cornish, Peterhouse or any of their respective directors, officers, employees or agents as to any of the contents of this announcement in connection with the Open Offer or any other matter referred to in this announcement.

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROIKZGGMFVLGFZM
Date   Source Headline
21st Mar 20249:49 amRNSHalf-year Report
9th Feb 202411:19 amRNSNew ADVFN Italia website is launched
12th Jan 20242:00 pmRNSResult of Meeting
28th Dec 20231:10 pmRNSResult of AGM
21st Dec 20237:00 amRNSFinal Results
5th Dec 20234:00 pmRNSNotice of AGM
16th Nov 20231:30 pmRNSHolding(s) in Company
21st Sep 202312:00 pmRNSADFVN connects audience to Doceo content
15th Aug 20236:05 pmRNSCorporate update
9th Jun 20236:15 pmRNSDirector/PDMR Shareholding
2nd Jun 202312:14 pmRNSTrading and corporate update
16th May 20234:33 pmRNSHolding(s) in Company
5th May 20233:06 pmRNSTotal Voting Rights
4th Apr 20237:00 amRNSIssue of Equity
30th Mar 20232:07 pmRNSHolding(s) in Company
30th Mar 20232:05 pmRNSHolding(s) in Company
23rd Mar 20235:02 pmRNSHolding(s) in Company
23rd Mar 20235:01 pmRNSHolding(s) in Company
23rd Mar 20235:00 pmRNSHolding(s) in Company
23rd Mar 20233:30 pmRNSDirector/PDMR Shareholding
20th Mar 20236:20 pmRNSAdmission update
14th Mar 202312:05 pmRNSFurther equity issue under the Open Offer
6th Mar 20237:00 amRNSHalf-year Report
6th Feb 202311:53 amRNSDirectorate Change
13th Jan 202311:19 amRNSResult of AGM
11th Jan 20231:15 pmRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
10th Jan 20237:00 amRNSCorporate update
9th Jan 20235:22 pmRNSTotal voting rights, Director / PDMR shareholding
6th Jan 20232:04 pmRNSFinal Results of Open Offer
6th Jan 20237:00 amRNSResults of Open Offer
20th Dec 20227:00 amRNSOpen Offer timetable and AGM
6th Dec 20227:00 amRNSOpen Offer
6th Dec 20227:00 amRNSFinal Results
28th Nov 20227:00 amRNSCorporate update
15th Sep 202210:45 amRNSAppointment of joint corporate broker
19th Aug 20224:15 pmRNSCorporate update
8th Aug 20227:00 amRNSDirectorate Change
6th Jun 20227:00 amRNSTrading and Corporate Update
29th Apr 20222:05 pmRNSResult of Meeting
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20222:01 pmRNSHolding(s) in Company
22nd Apr 20224:00 pmRNSTotal Voting Rights
20th Apr 202211:05 amRNSSecond Price Monitoring Extn
20th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20229:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.